We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Industry

Advanced Cell Diagnostics and Definiens Develop Quantitative Biomarker Tools

A technological leader in molecular pathology, Advanced Cell Diagnostics, has partnered with a provider for biomedical imaging and data analyses. More...
25 Apr 2011

The Binding Site Acquired by Investment Group

The Binding Site has been acquired by Nordic Capital, a private equity fund investment specializing in acquisitions in Nordic countries, currently investing Fund VII. More...
20 Apr 2011

Quest Diagnostics and Celera Enter Merger Agreement

Quest Diagnostics and Celera, a pioneer in genetic diagnostics discovery and development, have entered into a definitive merger agreement under which Quest Diagnostics will acquire Celera. More...
12 Apr 2011

Qiagen Buys Australian Biotech Company, Expands Molecular Diagnostics Portfolio

Qiagen has offered US$355 million to purchase the Australian Biotechnology company, Cellestis, expanding its molecular diagnostics product portfolio. More...
11 Apr 2011

ARIAD and MolecularMD Collaborate on Companion Diagnostic Test

ARIAD Pharmaceuticals and MolecularMD have entered into an exclusive collaboration agreement to develop a diagnostic test for leukemia patients. More...
06 Apr 2011

Olympus Licenses Digital Pathology Patents to Leica Microsystems

Olympus America and Leica Microsystems entered into a nonexclusive worldwide licensing agreement allowing Leica to access an extensive portfolio of patents held by Olympus in the field of digital pathology and virtual microscopy. More...
05 Apr 2011

SuperNova Diagnostics Enters Agreement with KSB Diagnostics of China

SuperNova Diagnostics signed an agreement with Shenzhen Kang Sheng Bao Bio-Technology, a biotechnology diagnostics company specializing in research, manufacture, and distribution of in vitro diagnostic kits and research reagents. More...
23 Mar 2011
Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
COVID-19 Antigen Self-Test
Panbio COVID-19 Antigen Self-Test


LabMedica Industry News channel reports on mergers and takeovers, on cooperative agreements and on trends in the IVD industry worldwide.